Myriad Genetics (MYGN) EPS Diluted (Annual): -3.951

Myriad Genetics, Inc. (MYGN)

4.26 +0.18 (+4.41%) USD | NASDAQ | Oct 14, 14:13

EPS Diluted (Annual) Chart

Historical EPS Diluted (Annual) Data

View and export this data back to 1995. Start Trial.

Date	Value
December 31, 2025	-3.951
December 31, 2024	-1.405
December 31, 2023	-3.18
December 31, 2022	-1.390
December 31, 2021	-0.3487
June 30, 2020	-2.685
June 30, 2019	0.0605
June 30, 2018	1.851
June 30, 2017	0.298
June 30, 2016	1.71
June 30, 2015	1.08
June 30, 2014	2.25
June 30, 2013	1.77
June 30, 2012	1.30
June 30, 2011	1.10
June 30, 2010	1.54

Date	Value
June 30, 2009	0.86
June 30, 2008	0.51
June 30, 2007	-0.425
June 30, 2006	-0.525
June 30, 2005	-0.65
June 30, 2004	-0.745
June 30, 2003	-0.48
June 30, 2002	-0.295
June 30, 2001	-0.155
June 30, 2000	-0.1375
June 30, 1999	-0.3375
June 30, 1998	-0.3125
June 30, 1997	-0.2575
June 30, 1996	-0.195
June 30, 1995	0.00

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Annual) Range, Past 5 Years

View EPS Diluted (Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

EPS Diluted (Annual) Benchmarks

View EPS Diluted (Annual) Benchmarks